GlassScriptPhysician profile
Mauro Giordani
NPI 1568568152
$49,621.22
in general payments reported to CMS, 2019-2025
18 companies · $554 in 2025
The $554 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $19K · 2021: $14K · 2022: $2,348 · 2023: $743 · 2024: $643 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,940.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap Implant Systems, LLC | $39,839.28 | 2019-2022 | |
| Orthalign INC | $4,165.24 | 2019-2025 | Orthalign Plus |
| Stryker Corporation | $1,325.88 | 2019-2025 | Mako |
| Depuy Synthes Sales INC. | $1,220.40 | 2019 | |
| Aesculap Akademie Gmbh | $662.10 | 2019 | |
| Zimmer Biomet Holdings, INC. | $478.51 | 2019-2023 | |
| Aesculap Ag | $413.76 | 2019 | |
| Next Science LLC | $305.03 | 2021-2024 | Surgx, Blastx, Xperience |
| Bioventus LLC | $260.61 | 2019-2024 | Durolane |
| Smith+Nephew, INC. | $190.01 | 2020-2021 | |
| Bone Support INC. | $144.17 | 2024 | Ceramentbone Void Filler, Cerament G |
| Innovation Technologies INC | $110.74 | 2025 | Irrisept |
| Osteoremedies, LLC | $106.03 | 2025 | Remedy Spacer, Xperience, Remedy Spectrum Gv Spacer |
| Medical Device Business Services, INC. | $99.76 | 2021-2023 | Attune |
| Avanos Medical | $96.78 | 2023 | On-Q* Pump and Accessories |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $92.06 | 2025 | Surgiflo Hemostatic Matrix |
| Aesculap, INC. | $82.86 | 2021 | |
| Sanara Medtech INC. | $28.00 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mauro Giordani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.